Clearfield: Data Center Product NOVA Gains Traction, but Core Fiber Slowdown Persists

What happened

Clearfield's NOVA data center product is seeing unexpected early adoption, leading management to adopt a more optimistic tone. However, the company's core fiber deployment business continues to face headwinds from weak near-term demand and a 20% sequential decline in backlog. The BEAD program remains a wildcard, with less than $10M revenue expected in FY26, and the company's heavily back-end-loaded guidance lacks visibility. On the positive side, Clearfield's balance sheet is strong with $100M net cash and ongoing buybacks, and the stock trades at just 2.5x EV/Sales versus peer multiples of 10x. The data center opportunity adds a new growth vector, but it is early and does not yet offset the underlying volatility in the legacy fiber business.

Implication

For investors, the data center opportunity provides a potential upside catalyst that was not present in the earlier DeepValue analysis, which focused solely on BEAD and MSO cycles. However, the core business still faces order lumpiness, customer concentration, and a weak Q1 FY26 guide, so the base case remains a gradual recovery to ~$165M FY26 revenue. If NOVA scales meaningfully, it could accelerate revenue growth and justify a higher multiple, supporting the bull case toward $40. But the thesis should remain cautious until backlog stabilizes and BEAD orders materialize; a more attractive entry is near $26 if the core business stumbles. The balance sheet provides a floor, so downside is limited, but near-term upside is capped until execution improves.

Thesis delta

The Seeking Alpha article introduces a new data center product catalyst (NOVA) that was not a central part of the earlier DeepValue thesis, shifting the narrative from a pure-play fiber broadband recovery story to one with potential data center tailwinds. Management's tone has turned more optimistic, but the fundamental challenges of low backlog and back-end-loaded guidance remain unchanged. The thesis now includes a higher bull-case probability if NOVA traction validates, but the WAIT rating is still appropriate until evidence of sustained order growth emerges.